Lipoprotein(a): a not-so-well-known risk factor for the development of cardiovascular disease in patients with type 2 diabetes mellitus

키워드

참고문헌 (15)

1. Hoover-Plow J, "Lipoprotein(a) metabolism: potential sites for therapeutic targets", Metabolism, 62, pp.479~491 (2013)
2. Berthold HK, "Hyperlipoproteinemia(a): clinical significance and treatment options", Atheroscler Suppl, 14, pp.1~5 (2013)
3. Børge G. Nordestgaard, "Lipoprotein (a) as a cause of cardiovascular disease: insights from epidemiology, genetics, and biology", Journal of Lipid Research, 57(11), pp.1953~1975 (2016), American Society for Biochemistry & Molecular Biology (ASBMB)[DOI]
4. Sandholzer C, "Effects of the apolipoprotein(a) size polymorphism on the lipoprotein(a) concentration in 7 ethnic groups", Hum Genet, 86, pp.607~614 (1991)
5. Guan W, "Race is a key variable in assigning lipoprotein(a) cutoff values for coronary heart disease risk assessment: the Multi-Ethnic Study of Atherosclerosis", Arterioscler Thromb Vasc Biol, 35, pp.996~1001 (2015)
6. Tae Seok Lim, "Elevated lipoprotein(a) levels predict cardiovascular disease in type 2 diabetes mellitus: a 10-year prospective cohort study", The Korean Journal of Internal Medicine, 31(6), pp.1110~1119 (2016), 대한내과학회[DOI]
7. 이현종, "외견상 건강한 한국인의 혈중 Lipoprotein(a)분포와 심혈관질환의 다른 위험인자와의 연관성", Korean Circulation Journal, 36(2), pp.150~158 (2006), 대한심장학회
8. Haffner SM, "Lp(a)concentrations in NIDDM", Diabetes, 41, pp.1267~1272 (1992)
9. Ding L, "Serum lipoprotein (a) concentrations are inversely associated with T2D, prediabetes, and insulin resistance in a middle-aged and elderly Chinese population", J Lipid Res, 56, pp.920~926 (2015)
10. Jenner JL, "Effects of age, sex, and menopausal status on plasma lipoprotein(a)levels: the Framingham Offspring Study", Circulation, 87, pp.1135~1141 (1993)
11. phenotypes in Caucasians and African Americans: the CARDIA study, "Arterioscler Thromb", 1993, 1037~1045
12. Emerging Risk Factors Collaboration, "Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality", JAMA, 302, pp.412~423 (2009)
13. Brown SA, "Plasma lipid, lipoprotein cholesterol, and apoprotein distributions in selected US communities: the Atherosclerosis Risk in Communities (ARIC) Study", Arterioscler Thromb, 13, pp.1139~1158 (1993)
14. AIM-HIGH Investigators, "Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy", N Engl J Med, 365, pp.2255~2267 (2011)
15. Ko HS, "Effect of fenofibrate on lipoprotein(a) in hypertriglyceridemic patients: impact of change in triglyceride level and liver function", J Cardiovasc Pharmacol, 46, pp.405~411 (2005)

관련 논문AI추천